March 3, 2021
FDA Issues EUA for Monoclonal Antibody Treatment of COVID-19
The U.S. Food and Drug Administration issued an emergency use authorization for simultaneous administration of monoclonal antibodies bamlanivimab and etesevimab to treat COVID-19 patients who meet specific criteria.